An open-label, multinational, multicentre, phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients with HER2-positive early or metastatic breast cancer (UmbHER1): Interim safety results from early breas
| Affiliation auteurs | Affiliation ok |
| Titre | An open-label, multinational, multicentre, phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients with HER2-positive early or metastatic breast cancer (UmbHER1): Interim safety results from early breas |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Pivot X., Poole C., Martin M., Gligorov J., Barrios C.H, Vrdoljak E., Gianni L., Tije A.JTen, Machackova Z., Truman M., Steger G. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 27 |
| Date Published | OCT 1 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1093/annonc/mdw364.66 |